Review: Apolipoprotein E gene polymorphism and gender

Annals of Clinical and Laboratory Science

Volumn 39, Issue 2, 2009, Pages 120-133

  Kolovou, Genovefa D ^a,b   Damaskos, Dimitris ^a   Anagnostopoulou, Katherine ^a   Cokkinos, Dennis V ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Apolipoprotein E; Coronary heart disease; Gene polymorphism

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEOHEPARAN SULFATE; TRIACYLGLYCEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ESTROGEN;

AGING; ALLELE; AMINO ACID SUBSTITUTION; BODY COMPOSITION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DNA POLYMORPHISM; FAT CONTENT; FAT INTAKE; GENE DUPLICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GROUPS BY AGE; HOMEOSTASIS; HUMAN; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOLYSIS; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; ARTICLE; BIOSYNTHESIS; BLOOD; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; GENETIC POLYMORPHISM; GENETICS; LIVER; MALE; METABOLISM; ONSET AGE; RISK FACTOR; SEXUAL DEVELOPMENT;

AGE OF ONSET; AGING; APOLIPOPROTEIN A-I; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CORONARY DISEASE; ESTROGENS; FEMALE; GENOTYPE; HUMANS; LIPIDS; LIVER; MALE; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS;

EID: 66349129242     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. MacKay J, Mensah GA: The Atlas of Heart Disease and Stroke. World Health Organization, Geneva, 2004.
2. Khaw KT. Epidemiology of coronary heart disease in women. Heart 2006;92 Suppl 3:iii2-4.
3. Hopkins PN, Stephenson S, Wu LL, Riley WA, Xin Y, Hunt SC. Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 2001;87:547-553. (Pubitemid 32178448)
4. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987;114:1467-1503. (Pubitemid 18009506)
5. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
6. Mahley RW, Rall SC, Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507-537.
7. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-349. (Pubitemid 21891679)
8. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004;141:137-147. (Pubitemid 38937836)
9. Fazio S, Linton MF. Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse. Circulation 2005;111:3349-3351. (Pubitemid 40923387)
10. Rezaee F, Gijbels MJ, Offerman EH, van der Linden M, De Maat MP, Verheijen JH. Overexpression of fibrinogen in ApoE*3-Leiden transgenic mice does not influence the progression of diet-induced atherosclerosis. Thromb Haemost 2002;88:329-334.
11. Davignon J, Cohn JS, Mabile L, Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 1999;286:115-143.
12. Kardia SL, Haviland MB, Ferrell RE, Sing CF. The relationship between risk factor levels and presence of coronary artery calcification is dependent on apolipoprotein E genotype. Arterioscler Thromb Vasc Biol 1999;19:427-435. (Pubitemid 29072760)
13. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994;272:1666-1671.
14. Rall SC Jr, Weisgraber KH, Mahley RW. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 1982;257:4171-4178.
15. Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 1999;40:1-16. (Pubitemid 29022581)
16. Taira K, Bujo H, Hirayama S, Yamazaki H, Kanaki T, Takahashi K, Ishii I, Miida T, Schneider WJ, Saito Y. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro. Arterioscler Thromb Vasc Biol 2001;21:1501-1506. (Pubitemid 34219815)
17. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 1991;11:1100-1110.
18. Huang Y, Liu XQ, Rall SC Jr, Mahley RW. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceriderich lipoproteins. J Biol Chem 1998;273:17483-17490. (Pubitemid 28355080)
19. Huang Y, Liu XQ, Rall SC Jr, Taylor JM, von Eckardstein A, Assmann G, Mahley RW. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem 1998;273:26388-26393. (Pubitemid 28471643)
20. Rensen PC, van Berkel TJ. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem 1996;271:14791-14799. (Pubitemid 26194959)
21. Huang Y, von Eckardstein A, Wu S, Maeda N, Assmann G. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. PNAS USA 1994;91:1834-1838. (Pubitemid 24080300)
22. Hui DY, Harmony JA. Inhibition of Ca2+ accumulation in mitogen-activated lymphocytes: role of membrane-bound plasma lipoproteins. PNAS USA 1980;77:4764-4768.
23. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21. (Pubitemid 18049171)
24. Luo CC, Li WH, Moore MN, Chan L. Structure and evolution of the apolipoprotein multigene family. J Mol Biol 1986;187:325-340. (Pubitemid 16083775)
25. Scott J, Knott TJ, Shaw DJ, Brook JD. Localization of genes encoding apolipoproteins CI, CII, and E to the p13 - cen region of human chromosome 19. Hum Genet 1985;71:144-146.
26. Weisgraber KH, Rall SC Jr, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 1981;256:9077-9083. (Pubitemid 12208303)
27. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, Visvikis S. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995;41:1068-1086.
28. Hoffmann MM, Scharnagl H, Koster W, Winkler K, Wieland H, Marz W. Apolipoprotein E1 Baden (Arg(180) - >Cys). A new apolipoprotein E variant associated with hypertriglyceridemia. Clin Chim Acta 2001;303:41-48.
29. Gomez-Coronado D, Alvarez JJ, Entrala A, Olmos JM, Herrera E, Lasuncion MA. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins. Atherosclerosis 1999;147:167-176. (Pubitemid 29486786)
30. Bioletto S, Fontana P, Darioli R, James RW. Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles. Atherosclerosis 1998;138:207-215. (Pubitemid 28255169)
31. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-1577. (Pubitemid 18007127)
32. Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, Goldstein JL, Brown MS, Schonfeld G, Hazzard WR, Blum C. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 1982;23:911-914. (Pubitemid 13244364)
33. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet 1987;27:567-582. (Pubitemid 17103694)
34. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548. (Pubitemid 20107994)
35. Li Z, McNamara JR, Fruchart JC, Luc G, Bard JM, Ordovas JM, Wilson PW, Schaefer EJ. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res 1996;37:1886-1896. (Pubitemid 26307669)
36. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Aamodt RL, Brewer HB Jr. Human apo-lipoprotein A-I and A-II metabolism. J Lipid Res 1982;23:850-862. (Pubitemid 13244359)
37. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab 1983;57:262-267.
38. Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 1996;16:431-440. (Pubitemid 126439028)
39. Williams CM. Lipid metabolism in women. Proc Nutr Soc 2004;63:153-160. (Pubitemid 38543883)
40. Mittendorfer B, Fields DA, Klein S. Excess body fat in men decreases plasma fatty acid availability and oxidation during endurance exercise. Am J Physiol Endocrinol Metab 2004;286:E354-362. (Pubitemid 38292684)
41. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 2004;50:1189-1200. (Pubitemid 38824227)
42. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18:1046-1053. (Pubitemid 28323588)
43. Abbott RD, Garrison RJ, Wilson PW, Epstein FH, Castelli WP, Feinleib M, LaRue C. Joint distribution of lipoprotein cholesterol classes. The Framingham study. Arteriosclerosis 1983;3:260-272.
44. Connor SL, Connor WE, Sexton G, Calvin L, Bacon S. The effects of age, body weight and family relationships on plasma lipoproteins and lipids in men, women and children of randomly selected families. Circulation 1982;65:1290-1298.
45. Kottke BA, Moll PP, Michels VV, Weidman WH. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc 1991;66:1198-1208.
46. Kritchevsky D. How aging affects cholesterol metabolism. Postgrad Med 1978;63:133-136,138. (Pubitemid 8302913)
47. Kolovou GD, Bilianou HG. Influence of aging and menopause on lipids and lipoproteins in women. Angiology 2008;59(2 Suppl):54S-57S.
48. Williams EL, Winkleby MA, Fortmann SP. Changes in coronary heart disease risk factors in the 1980s: evidence of a male-female crossover effect with age. Am J Epidemiol 1993;137:1056-1067. (Pubitemid 23191073)
49. Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, Gordon DJ, Burt VL, Brown CD, Lippel K, et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993;269:3002-3008.
50. Hasegawa T, Nakasato Y, Sasaki M. Factor analysis of lifestyle-related factors in 12,525 urban Japanese subjects. J Atheroscler Thromb 2005;12:29-34.
51. Lemieux S, Despres JP. Metabolic complications of visceral obesity: contribution to the aetiology of type 2 diabetes and implications for prevention and treatment. Diabetes Metab 1994;20:375-393.
52. Lemieux S, Despres JP, Moorjani S, Nadeau A, Theriault G, Prud'homme D, Tremblay A, Bouchard C, Lupien PJ. Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia 1994;37:757-764.
53. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, Despres JP. Gender difference in postprandial lipemia : importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999;19:2448-2455.
54. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, Tsarpalis K, Damaskos DS, Manolis A, Cokkinos DV. Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis 2005;4:21. (Pubitemid 41584026)
55. Kolovou GD, Anagnostopoulou KK, Pilatis N, Kafaltis N, Sorodila K, Psarros E, Cokkinos DV. Low fasting low high-density lipoprotein and postprandial lipemia. Lipids Health Dis 2004;3:18. (Pubitemid 40217453)
56. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res 1988;29:925-936. (Pubitemid 18182761)
57. Georgopoulos A, Rosengard AM. Abnormalities in the metabolism of postprandial and fasting triglyceride-rich lipoprotein subfractions in normal and insulin-dependent diabetic subjects: effects of sex. Metabolism 1989;38:781-789. (Pubitemid 19205586)
58. Kovar J, Poledne R. Sex differences in the response of postprandial lipemia to a change from a low-fat low-cholesterol diet to a high-fat high-cholesterol diet. Physiol Res 2000;49:233-239. (Pubitemid 30365883)
59. Kolovou GD, Daskalova D, Iraklianou SA, Adamopoulou EN, Pilatis ND, Hatzigeorgiou GC, Cokkinos DV. Postprandial lipemia in hypertension. J Am Coll Nutr 2003;22:80-87. (Pubitemid 36164461)
60. Kolovou GD, Anagnostopoulou KK, Pilatis ND, Giannopoulou M, Hoursalas IS, Pavlidis AN, Adamopoulou E, Valaora AI, Mikhailidis DP, Cokkinos DV. The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia. J Womens Health 2004;13:1119-1126.
61. Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B, Schnohr P, Tybjaerg-Hansen A. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res 2000;41:1812-1822.
62. Kamboh MI, Bunker CH, Aston CE, Nestlerode CS, McAllister AE, Ukoli FA. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol 1999;16:205-222. (Pubitemid 29070265)
63. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 1991;11:1330-1348.
64. Stengard JH, Clark AG, Weiss KM, Kardia S, Nickerson DA, Salomaa V, Ehnholm C, Boerwinkle E, Sing CF. Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet 2002;71:501-517. (Pubitemid 34970122)
65. Boerwinkle E, Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 1988;42:104-112. (Pubitemid 18081287)
66. Lussier-Cacan S, Bolduc A, Xhignesse M, Niyonsenga T, Connelly PW, Sing CF. Impact of age and body size on interindividual variation in measures of lipid metabolism: influence of gender and apolipoprotein E genotype. Clin Genet 2000;57:35-47. (Pubitemid 30105559)
67. Morbois-Trabut L, Chabrolle C, Garrigue MA, Lasfargues G, Lecomte P. Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients. Diabetes Metab 2006;32:270-275. (Pubitemid 43966752)
68. Leon AS, Togashi K, Rankinen T, Despres JP, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE family study. Metabolism 2004;53:108-116. (Pubitemid 38071945)
69. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002;155:487-495. (Pubitemid 34208040)
70. Moreno JA, Lopez-Miranda J, Marin C, Gomez P, Perez- Martinez P, Fuentes F, Fernandez de la Puebla RA, Paniagua JA, Ordovas JM, Perez-Jimenez F. The influence of the apolipoprotein E gene promoter (-219G/ T) polymorphism on postprandial lipoprotein metabolism in young normolipemic males. J Lipid Res 2003;44:2059-2064. (Pubitemid 37509621)
71. Viiri LE, Raitakari OT, Huhtala H, Kahonen M, Rontu R, Juonala M, Hutri-Kahonen N, Marniemi J, Viikari JS, Karhunen PJ, Lehtimaki T. Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults. J Lipid Res 2006;47:1298-1306. (Pubitemid 43830722)
72. Scuteri A, Bos AJ, Zonderman AB, Brant LJ, Lakatta EG, Fleg JL. Is the apoE4 allele an independent predictor of coronary events? Am J Med 2001;110:28-32.
73. Frikke-Schmidt R, Tybjaerg-Hansen A, Steffensen R, Jensen G, Nordestgaard BG. Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 2000;35:1192-1199. (Pubitemid 30206894)
74. Stankovic S, Glisic S, Alavanatic D. The effect of a gender difference in the apolipoprotein E gene DNA polymorphism on serum lipid levels in a Serbian healthy population. Clin Chem Lab Med 2000;38:539-544. (Pubitemid 30639384)
75. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PW. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler Thromb 1994;14:1105-1113.
76. Chen Q, Reis SE, Kammerer CM, McNamara DM, Holubkov R, Sharaf BL, Sopko G, Pauly DF, Bairey Merz CN, Kamboh MI. APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study. Atherosclerosis 2003;169:159-167. (Pubitemid 36830935)
77. Mahley RW, Pepin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype. J Lipid Res 2000;41:1290-1301. (Pubitemid 30666894)
78. Somekawa Y, Wakabayashi A. Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 1998;79:185-191. (Pubitemid 28294912)
79. Garry PJ, Baumgartner RN, Brodie SG, Montoya GD, Liang HC, Lindeman RD, Williams TM. Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene. Clin Chem 1999;45:1214-1223. (Pubitemid 29424260)
80. Tiret L, de Knijff P, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb 1994;14:1617-1624.
81. Lehtinen S, Lehtimaki T, Sisto T, Salenius JP, Nikkila M, Jokela H, Koivula T, Ebeling F, Ehnholm C. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 1995;114:83-91.
82. Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet 1991;49:1155-1166.
83. Chivot L, Mainard F, Bigot E, Bard JM, Auget JL, Madec Y, Fruchart JC. Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E. Atherosclerosis 1990;82:205-211. (Pubitemid 20183590)
84. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke 1993;24:661-664.
85. Buring JE, O'Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB, Breslow JL, Hennekens CH. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation 1992;85:22-29.
86. Bittolo Bon G, Cazzolato G, Saccardi M, Kostner GM, Avogaro P. Total plasma apo E and high density lipoprotein apo E in survivors of myocardial infarction. Atherosclerosis 1984;53:69-75. (Pubitemid 14041914)
87. Garces C, Benavente M, Ortega H, Rubio R, Lasuncion MA, Rodriguez Artalejo F, Fernandez Pardo J, de Oya M. Influence of birth weight on the apo E genetic determinants of plasma lipid levels in children. Pediatr Res 2002;52:873-878. (Pubitemid 35379467)
88. Infante-Rivard C, Levy E, Rivard GE, Guiguet M, Feoli-Fonseca JC. Small babies receive the cardiovascular protective apolipoprotein epsilon 2 allele less frequently than expected. J Med Genet 2003;40:626-629. (Pubitemid 37046919)
89. Isasi CR, Shea S, Deckelbaum RJ, Couch SC, Starc TJ, Otvos JD, Berglund L. Apolipoprotein epsilon2 allele is associated with an anti-atherogenic lipoprotein profile in children: The Columbia University BioMarkers Study. Pediatrics 2000;106:568-575. (Pubitemid 30664145)
90. Choi YH, Kim JH, Kim DK, Kim JW, Lee MS, Kim CH, Park SC. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. J Gerontol A Biol Sci Med Sci 2003;58:227-231. (Pubitemid 36307593)
91. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32. (Pubitemid 24191909)
92. Lewis SJ, Brunner EJ. Methodological problems in genetic association studies of longevity-the apolipoprotein E gene as an example. Int J Epidemiol 2004;33:962-970. (Pubitemid 39429988)
93. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci 2001;56:M75-78. (Pubitemid 32121420)
94. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L. APOE-related mortality: Effect of dementia, cardiovascular disease and gender. Neurobiol Aging 2008 (in press).
95. Evans AE, Zhang W, Moreel JF, Bard JM, Ricard S, Poirier O, Tiret L, Fruchart JC, Cambien F. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men. Hum Genet 1993;92:191-197. (Pubitemid 23272288)
96. Eto M, Watanabe K, Ishii K. A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations. Clin Genet 1986;30:422-427. (Pubitemid 17200192)
97. Asakawa J, Takahashi N, Rosenblum BB, Neel JV. Two-dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet 1985;70: 222-230. (Pubitemid 15234375)
98. Tsuchiya S, Yamanouchi Y, Onuki M, Yamakawa K, Miyazaki R, Taya T, Kondo I, Ohnuki M, Hamaguchi H. Frequencies of apolipoproteins E5 and E7 in apparently healthy Japanese. Jinrui Idengaku Zasshi 1985;30:271-278. (Pubitemid 16115955)
99. Baroni MG, Berni A, Romeo S, Arca M, Tesorio T, Sorropago G, Di Mario U, Galton DJ. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Med Genet 2003;4:8. (Pubitemid 38692970)
100. Hsieh MC, Lin SR, Yang YC, Chen HC, Lin JN, Shin SJ. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. J Nephrol 2002;15:368-373.
101. James RW, Boemi M, Giansanti R, Fumelli P, Pometta D. Underexpression of the apolipoprotein E4 isoform in an Italian population. Arterioscler Thromb 1993;13:1456-1459. (Pubitemid 23303398)
102. Bailleul S, Couderc R, Landais V, Lefevre G, Raichvarg D, Etienne J. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum Hered 1993;43:159-165. (Pubitemid 23096226)
103. Kolovou G, Yiannakouris N, Hatzivassiliou M, Malakos J, Daskalova D, Hatzigeorgiou G, Cariolou MA, Cokkinos DV. Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease. Curr Med Res Opin 2002;18:118-124. (Pubitemid 34665748)
104. Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255.
105. Eubank DC. Differences in the association between apolipoprotein E genotype and mortality across populations. J Gerontol A Biol Sci Med Sci 2007;62:899-907. (Pubitemid 350131676)
106. Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, Osgood D, Parpos S, Pedro-Botet J, Daly JA, Ordovas JM. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001;154:529-537. (Pubitemid 32232149)
107. Kolovou GD, Anagnostopoulou KK, Salpea KD, Panagiotakos DB, Hoursalas IS, Cariolou MA, Koniavitou K, Cokkinos DV. Apolipoprotein E genotype in matched men and women with coronary heart disease. Ann Clin Lab Sci 2005;35:391-396. (Pubitemid 41579568)
108. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-167.
109. Kolovou GD, Anagnostopoulou KK, Cokkinos DV. Apolipoprotein E gene polymorphism and myocardial infarction. Int J Cardiol 2008 (in press).
110. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-235. (Pubitemid 16097321)
111. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993;39:2125-2129. (Pubitemid 23306162)
112. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T, Yokota M. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 2003;42:1429-1437. (Pubitemid 37267286)
113. van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-880.
114. Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984;65:237-241. (Pubitemid 14182014)
115. Cumming AM, Robertson FW. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet 1984;25:310-313. (Pubitemid 14157792)
116. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 1986;32:778-781. (Pubitemid 17028348)
117. Yamamura T, Tajima S, Miyake Y, Nomura S, Yamamoto A, Haze K, Hiramori K. Hyperlipoproteinemia as a risk factor for ischemic heart disease. Jpn Circ J 1990;54:448-456. (Pubitemid 20315535)
118. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JB, Cambien F, et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 1994;14:1412-1419. (Pubitemid 24282638)
119. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-269.
120. Eto M, Watanabe K, Makino I. Increased frequencies of apolipoprotein epsilon 2 and epsilon 4 alleles in patients with ischemic heart disease. Clin Genet 1989;36:183-188. (Pubitemid 19218461)
121. Eichner JE, Kuller LH, Ferrell RE, Meilahn EN, Kamboh MI. Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study. Arteriosclerosis 1990;10:379-385.
122. Kolovou GD, Anagnostopoulou KK, Mikhailidis DP, Panagiotakos DB, Pilatis ND, Cariolou MA, Yiannakouris N, Degiannis D, Stavridis G, Cokkinos DV. Association of apolipoprotein E genotype with early onset of coronary heart disease in Greek men. Angiology 2005;56:663-670. (Pubitemid 41790974)